Search Result "Proprotein convertase subtilisin/kexin type 9 inhibitors (PCSK9)"
Natural Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitors: A Review
Journal: Combinatorial Chemistry & High Throughput Screening
Volume: 26 Issue: 15 Year: 2023 Page: 2668-2678
Author(s):
Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) and LDL Lowering in the Contemporary Management of Dyslipidemia
Journal: Cardiovascular & Hematological Agents in Medicinal Chemistry
Volume: 11 Issue: 4 Year: 2013 Page: 281-288
Author(s): Maryna Popp Switzer,Azikiwe C. Nwosu,Zinnia San Juan,Debabrata Mukherjee
Structure and Function of Proprotein Convertase Subtilisin/kexin Type 9 (PCSK9) in Hyperlipidemia and Atherosclerosis
Journal: Current Drug Targets
Volume: 20 Issue: 10 Year: 2019 Page: 1029-1040
Author(s): Xinjie Lu
The Role of Proprotein Convertase Subtilisin-Kexin Type 9 Inhibitors in the Management of Dyslipidemia
Journal: Current Pharmaceutical Design
Volume: 23 Issue: 10 Year: 2017 Page: 1495-1499
Author(s): Konstantinos Tziomalos
Proprotein Convertase Subtilisin/kexin type 9 Inhibition in Cardiovascular Prevention
Journal: Current Pharmaceutical Design
Volume: 24 Issue: 4 Year: 2018 Page: 442-450
Author(s): Ali Ali,Pierluigi Costanzo,Angela Hoye
Treatment with Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) Inhibitors to Reduce Cardiovascular Inflammation and Outcomes
Journal: Current Medicinal Chemistry
Volume: 24 Issue: 1 Year: 2017 Page: 1403-1416
Author(s): Luca Liberale,Fabrizio Montecucco,Giovanni G. Camici,Franco Dallegri,Alessandra Vecchie,Federico Carbone,Aldo Bonaventura
Regulatory Effects of Peptides from the Pro and Catalytic Domains of Proprotein Convertase Subtilisin/Kexin 9 (PCSK9) on Low-Density Lipoprotein Receptor (LDL-R)
Journal: Current Medicinal Chemistry
Volume: 17 Issue: 2 Year: 2010 Page: 2168-2182
Author(s): H. Palmer-Smith, A. Basak
Dyslipidaemias and Cardiovascular Disease: Focus on the Role of PCSK9 Inhibitors
Journal: Current Medicinal Chemistry
Volume: 27 Issue: 27 Year: 2020 Page: 4494-4521
Author(s): Olga Panagiotopoulou,Scott T. Chiesa,Dimitrios Tousoulis,Marietta Charakida
Proprotein Convertase Subtilisin Kexin 9 (PCSK9) Inhibitors in the Treatment of Hypercholesterolemia and other Pathologies
Journal: Current Pharmaceutical Design
Volume: 19 Issue: 1 Year: 2013 Page: 3161-3172
Author(s): Nabil G. Seidah
PCSK9 Inhibition - A Novel Mechanism to Treat Lipid Disorders?
Journal: Current Pharmaceutical Design
Volume: 19 Issue: 2 Year: 2013 Page: 3869-3877
Author(s): Maciej Banach, Manfredi Rizzo, Milan Obradovic, Giuseppe Montalto, Jacek Rysz, Dimitri P. Mikhailidis, Esma R. Isenovic